A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation

Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
11/2004
11/24/2004	EP1478735A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
11/24/2004	EP1478396A1 Process for the preparation of a nutrient formulation
11/24/2004	EP1478276A2 Novel targeted compositions for diagnostic and therapeutic use
11/24/2004	EP1107971B1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
11/24/2004	CN1549729A 化合物 Compound
11/23/2004	US6822092 Expanded porphyrins and a method for synthesis thereof
11/23/2004	US6821274 Ultrasound therapy for selective cell ablation
11/23/2004	CA2245766C Compositions useful in the phototherapeutic treatment of proliferative skin disorders
11/18/2004	WO2004099375A2 Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use therof
11/18/2004	WO2004098629A1 GnRH CONJUGATES COMPRISING A PHOTOSENSITIZER FOR PHOTODYNAMIC THERAPY
11/18/2004	WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents
11/18/2004	WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/18/2004	US20040230257 Enhanced bioavailability of nutrients, pharmaceutical agents, and other bioactive substances through laser resonant homogenization or modification of molecular shape or crystalline form
11/18/2004	US20040229830 Delivery of therapeutic compositions using ultrasound
11/18/2004	US20040228871 inducing differentiation in a cell with chemotherapeutic agent, then adding photosensitizer (chlorins)
11/18/2004	US20040228795 Injecting a photosensitizing agent into the rats body, irradiating the optic nerve with a laser to damage the optic nerve; use in optic nerve disease research, glaucoma eye disorders
11/17/2004	EP1476548A2 Process of cell electrofusion
11/17/2004	EP1476190A1 Amino-substituted hypocrellins for use as sonosensitizers
11/17/2004	CN1546040A Compisition as substitution of phthalocyanine cooperator and low density lipoprotein and its preparation process
11/16/2004	US6818227 Liposome composition and method for administration of a radiosensitizer
11/11/2004	WO2004096206A2 Therapeutic combination of a cox-2 inhibitor and a tace inhibitor
11/11/2004	WO2004096190A1 Composition comprising magnetic nanoparticle encapsulating magnetic material and drug with biodegradable synthetic polymer
11/11/2004	WO2004082579A3 Nemorubicin as radiosensitizer in combination with radiation therapy against tumors
11/11/2004	WO2004069209A3 Compositions and methods for increasing the sensitivity of apoptosis-resistant tumor cells to inducers of apoptosis
11/11/2004	WO2004037287A3 Phototreatment device for use with coolants and topical substances
11/11/2004	WO2003087411A8 Method to inhibit cell growth using oligonucleotides
11/11/2004	US20040225198 Method for treatment of neurodegenerations
11/11/2004	US20040224029 Particle possessing a membrane
11/10/2004	EP1267897B1 Treatment of congestive heart failure by pretreated autologous blood
11/10/2004	EP1202671A4 Microparticles useful as ultrasonic contrast agents and for lymphatic system
11/10/2004	EP1140181B1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
11/10/2004	CN1174713C Microporation of human skin for drug delivery and monitoring applications
11/04/2004	WO2004093868A1 Therapeutic combination of a cox-2 inhibitor and an aromatase inhibitor
11/04/2004	WO2004093856A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004	US20040220456 Microporation of tissue for delivery of bioactive agents
11/04/2004	US20040219153 Synergistic tumorcidal response induced by histamine
11/04/2004	CA2821220A1 Magnetically controllable drug and gene delivery stents
11/04/2004	CA2821214A1 Magnetically controllable drug and gene delivery stents
11/04/2004	CA2522960A1 Therapeutic combination of a cox-2 inhibitor and an aromatase inhibitor
11/04/2004	CA2522667A1 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/03/2004	EP1472259A1 Tetrapyrrolic macrocycles as photodynamic agents
11/03/2004	EP1471940A2 Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitisers
11/03/2004	EP1471939A1 Delivery of neutron capture elements for neutron capture therapy
11/03/2004	EP1471822A1 DYE−BIOCONJUGATES FOR SIMULTANEOUS OPTICAL DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
11/03/2004	CN1173710C Treatment of congestive heart failure by pretreated autologous blood
11/02/2004	US6812209 Conjugate consisting of an active substance and a non-exogenous native protein
11/02/2004	US6812204 Delivery of an agent
10/2004
10/28/2004	WO2004092115A2 Hydroxamates as therapeutic agents
10/28/2004	WO2004091629A1 Methods and devices for epithelial protection during photodynamic therapy
10/28/2004	WO2004091592A2 Methods and compositions to treat myocardial conditions
10/28/2004	WO2004091531A2 Methods and devices for epithelial protection during photodynamic therapy
10/28/2004	WO2004016148A3 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
10/28/2004	WO2003086298A3 Use of interleukin-19 to treat ovarian cancer
10/28/2004	US20040215292 Photodynamic treatment of targeted cells
10/28/2004	US20040214001 Homogeneous nanoparticles comprising a nonconducting inner layer surrounded by an electroconducting material having a thickness which is determined by the wavelength of maximum absorbance or scattering of the particle; optical filters, chemical sensors and switches based on surface plasmon resonance
10/28/2004	US20040213986 Patterned, high surface area substrate with hydrophilic/hydrophobic contrast, and method of use
10/28/2004	US20040213774 Presbyopia treatment by lens alteration
10/28/2004	US20040213756 Methods and compositions to treat myocardial conditions
10/28/2004	US20040213737 Radioactive arsenic-containing compounds and their uses in the treatment of tumors
10/28/2004	DE19827417B4 Material zur unterschiedlichen Modifizierung der optischen Eigenschaften unterschiedlicher Zellen Material for different modification of the optical properties of different cells
10/28/2004	DE10316566A1 Mittel für die photodynamische Diagnostik und Therapie von bösartigen Tumoren Agents for photodynamic diagnosis and therapy of malignant tumors
10/27/2004	EP1470837A2 Switched photodynamic therapy apparatus and method
10/27/2004	EP1470821A2 Cell therapy method for the treatment of tumours
10/27/2004	EP1470139A2 NOVEL, WATER−SOLUBLE PORPHYRIN PLATINUM COMPOUNDS WITH HIGH TUMOR SELECTIVITY AND THEIR USE FOR THE TREATMENT OF BENIGN AND MALIGNANT TUMOR DISEASES
10/27/2004	EP1470127A1 N, n'-dimethylated n-confused porphyrins
10/27/2004	EP1469891A1 Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
10/27/2004	EP1469733A2 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
10/27/2004	EP1387701B1 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
10/27/2004	CN1541201A Aliphatic amino-substituted demethoxylated hyporcrellins and their synthesis
10/27/2004	CN1172668C Use of chelerythrine in prepn. of medicine
10/26/2004	US6808884 Intercalation compound for use in the diagnosis and detection of genetic disorders
10/26/2004	US6808720 Charged lipids and uses for the same
10/21/2004	WO2004089409A2 Agent for the photodynamic diagnosis and therapy of malignant tumors
10/21/2004	WO2004089356A2 Targeted bone marrow protection agents
10/21/2004	WO2004089300A2 Sapphyrins and uses thereof
10/21/2004	WO2004080284A3 Antibody-targeted photodynamic therapy
10/21/2004	WO2004045652A3 Biocompatible magnetic materials for the treatment of cancer by means of hyperthermia, and processes for their production
10/21/2004	US20040210184 Effect of electric field and ultrasound for transdermal drug delivery
10/21/2004	US20040208855 Use of PDT to inhibit intimal hyperplasia
10/21/2004	US20040208845 Delivering structurally reinforcing agents into a ventricle to increase compliance; prevention of remodeling and thinning of infarct zone by crosslinking collagen; pro-fibroblastic, antiischemic and angiogenic agents
10/21/2004	DE10315538A1 Teilchen mit einer Membran Particles having a membrane
10/21/2004	CA2520452A1 Sapphyrins and uses thereof
10/20/2004	EP1467761A1 Treatment of neovascular ophthalmic disease
10/20/2004	EP1467760A2 Systems and methods for photodynamic therapy
10/20/2004	EP1467706A2 Dermal application system for aminolevulinic acid-derivatives
10/19/2004	US6806363 Drugs for diagnosis/therapy; radionuclide-based tumor imaging
10/19/2004	US6806284 Reduces level of necessary systemic dose and side effects; promotes drug excretion; bacteriopheophorbide or pheophorbide with glucosamine moieties
10/14/2004	WO2004087765A1 Titanium dioxide complex having molecule distinguishability
10/14/2004	WO2004087577A1 Surface-modified titanium dioxide fine particles and dispersion comprising the same, and method for producing the same
10/14/2004	WO2004087208A1 Thermotherapeutic for malignant tumor comprising heat shock protein and fine magnetic particles
10/14/2004	WO2004087103A1 Ophthalmic drug delivery system using polymer micell
10/14/2004	WO2004087093A1 A topical agent containing niacin for application to the skin prior to luminous treatment
10/14/2004	WO2004067508A3 Use of photodynamic therapy therapeutic agents entrapped in ceramic nanoparticles
10/14/2004	US20040202663 Therapy for primary and metastatic cancers
10/14/2004	US20040202209 Quasi-phase-matching photodynamic therapy (PDT) and photodynamic diagnosis ( PDT) laser sources
10/14/2004	CA2520525A1 Ophthalmic drug delivery system using polymer micelle
10/13/2004	EP1465699A1 Photophoretic auto immune stimulation
10/13/2004	EP1349547B1 Use of 5-aminolevulinic acid for the prophylaxis of restenosis
10/13/2004	EP1250095B1 Versatile hydrophilic dyes
10/12/2004	US6803052 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma

1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 95